Publication Cover
Nutritional Neuroscience
An International Journal on Nutrition, Diet and Nervous System
Volume 23, 2020 - Issue 11
297
Views
5
CrossRef citations to date
0
Altmetric
Articles

Cognition and physical functioning in patients with schizophrenia: any role for vitamin D?

ORCID Icon, ORCID Icon, ORCID Icon, , , & show all

References

  • Heinrichs RW, Zakzanis KK. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology. 1998;12(3):426–45.
  • Saykin AJ, Shtasel DL, Gur RE, Kester DB, Mozley LH, Stafiniak P, et al. Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Arch Gen Psychiatry. 1994;51(2):124–31.
  • Targum SD, Keefe RS. Cognition and schizophrenia: is there a role for cognitive assessments in diagnosis and treatment? Psychiatry (Edgmont). 2008;5(12):55.
  • Mohamed S, Paulsen JS, O’leary D, Arndt S, Andreasen N. Generalized cognitive deficits in schizophrenia: a study of first-episode patients. Arch Gen Psychiatry. 1999;56(8):749–54.
  • Kuperberg G, Heckers S. Schizophrenia and cognitive function. Curr Opin Neurobiol. 2000;10(2):205–10.
  • Dickerson F, Boronow JJ, Ringel N, Parente F. Social functioning and neurocognitive deficits in outpatients with schizophrenia: a 2-year follow-up1. Schizophr Res. 1999;37(1):13–20.
  • Addington J, Addington D. Neurocognitive and social functioning in schizophrenia: a 2.5 year follow-up study. Schizophr Res. 2000;44(1):47–56.
  • Krishnadas R, Moore BP, Nayak A, Patel RR. Relationship of cognitive function in patients with schizophrenia in remission to disability: a cross-sectional study in an Indian sample. Ann Gen Psychiatry. 2007;6(1):19.
  • Hughes C, Kumari V, Soni W, Das M, Binneman B, Drozd S, et al. Longitudinal study of symptoms and cognitive function in chronic schizophrenia. Schizophr Res. 2003;59(2):137–46.
  • Raji MA, Al Snih S, Ostir GV, Markides KS, Ottenbacher KJ. Cognitive status and future risk of frailty in older Mexican Americans. J Gerontol A-Biol. 2010;65A(11):1228–34.
  • Kim J-S, Kim Y-I, Song C, Yoon I, Park J-W, Choi Y-B, et al. Association of vitamin D receptor gene polymorphism and Parkinson’s disease in Koreans. J Korean Med Sci. 2005;20(3):495–8.
  • Van Os JI. Does the urban environment cause psychosis? Br J Psychiatry. 2004;184(4):287–8
  • Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1α-hydroxylase in human brain. J Chem Neuroanat. 2005;29(1):21–30.
  • Haddad C, Zoghbi M, Hallits S, Bou Assai T, Hashim M, Nabout R. Vitamin D levels in Lebanese patients with schizophrenia: a case-control study. Ann Nutr Dis Ther. 2017;4(1):1041.
  • Menkes DB, Lancaster K, Grant M, Marsh RW, Dean P, du Toit SA. Vitamin D status of psychiatric inpatients in New Zealand’s Waikato region. BMC Psychiatry. 2012;12(1):68.
  • Valipour G, Saneei P, Esmaillzadeh A. Serum vitamin D levels in relation to schizophrenia: a systematic review and meta-analysis of observational studies. J Clin Endocrinol Metab. 2014;99(10):3863–72.
  • Nerhus M, Berg AO, Simonsen C, Haram M, Haatveit B, Dahl SR, et al. Vitamin D deficiency associated with cognitive functioning in psychotic disorders. J Clin Psychiatry. 2017;78(7):e750–57.
  • Nerhus M, Berg AO, Kvitland LR, Dieset I, Hope S, Dahl SR, et al. Low vitamin D is associated with negative and depressive symptoms in psychotic disorders. Schizophr Res. 2016;178(1):44–9.
  • Lerner PP, Sharony L, Miodownik C. Association between mental disorders, cognitive disturbances and vitamin D serum level: current state. Clin Nutr ESPEN. 2018;23:89–102.
  • Cieslak K, Feingold J, Antonius D, Walsh-Messinger J, Dracxler R, Rosedale M, et al. Low vitamin D levels predict clinical features of schizophrenia. Schizophr Res. 2014;159(2):543–5.
  • Graham K, Keefe R, Lieberman J, Calikoglu A, Lansing K, Perkins D. Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first-episode schizophrenia. Early Interv Psychiatry. 2015;9(5):397–405.
  • Eyles DW, Burne TH, McGrath JJ. Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front Neuroendocrinol. 2013;34(1):47–64.
  • McGrath JJ, Burne TH, Féron F, Mackay-Sim A, Eyles DW. Developmental vitamin D deficiency and risk of schizophrenia: a 10-year update. Schizophr Bull. 2010;36(6):1073–8.
  • Firth J, Carney R, Stubbs B, Teasdale SB, Vancampfort D, Ward PB, et al. Nutritional deficiencies and clinical correlates in first-episode psychosis: a systematic review and meta-analysis. Schizophr Bull. 2017;44(6):1275–92.
  • McGrath J, Saari K, Hakko H, Jokelainen J, Jones P, Järvelin M-R, et al. Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study. Schizophr Res. 2004;67(2–3):237–45.
  • DeLuca G, Kimball S, Kolasinski J, Ramagopalan S, Ebers G. The role of vitamin D in nervous system health and disease. Neuropathol Appl Neurobiol. 2013;39(5):458–84.
  • Obradovic D, Gronemeyer H, Lutz B, Rein T. Cross-talk of vitamin D and glucocorticoids in hippocampal cells. J Neurochem. 2006;96(2):500–9.
  • Association AP. Diagnostic and statistical manual of mental disorders (DSM-5®). Arlington: American Psychiatric Pub; 2013.
  • Reisberg B, Ferris SH. Brief cognitive rating scale (BCRS). Psychopharmacol Bull. 1988;24(4):629.
  • Affleck JW, McGuire RJ. The measurement of psychiatric rehabilitation status. A review of the needs and a new scale. Br J Psychiatry. 1984;145(5):517–25.
  • Hillhouse J, Turrisi R, Jaccard J, Robinson J. Accuracy of self-reported sun exposure and sun protection behavior. Prev Sci. 2012;13(5):519–31.
  • Haddad C, Zoghbi M, Hallit S, Bou-Assi T, Medlej-Hashim M, Nabout R. Vitamin D levels in Lebanese patients with schizophrenia: a case-control study. Ann Nutr Disord & Ther. 2017;4(1):1041.
  • Annweiler C, Montero-Odasso M, Llewellyn DJ, Richard-Devantoy S, Duque G, Beauchet O. Meta-analysis of memory and executive dysfunctions in relation to vitamin D. Journal of Alzheimer’s Disease. 2013;37(1):147–71.
  • Pettersen JA. Vitamin D and executive functioning: are higher levels better? J Clin Exp Neuropsychol. 2016;38(4):467–77.
  • Harvey PD. Cognitive functioning and disability in schizophrenia. Curr Dir Psychol Sci. 2010;19(4):249–54.
  • Brown S, Birtwistle J, Roe L, Thompson C. The unhealthy lifestyle of people with schizophrenia. Psychol Med. 1999;29(3):697–701.
  • Menkes DB. Vitamin D: don’t forget mental health. Br Med J. 2012;345:e5710.
  • Lauth M, Rohnalter V, Bergstrom A, Kooshesh M, Svenningsson P, Toftgard R. Anti-psychotic drugs regulate Hedgehog signaling by modulation of 7-dehydrocholesterol reductase levels. Mol Pharmacol. 2010;78(3):486–96.
  • Shinchuk LM, Morse L, Huancahuari N, Arum S, Chen TC, Holick MF. Vitamin D deficiency and osteoporosis in rehabilitation inpatients. Arch Phys Med Rehabil. 2006;87(7):904–8.
  • Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med. 1997;337(10):670–6.
  • Hill TR, Aspray TJ. The role of vitamin D in maintaining bone health in older people. Ther Adv Musculoskelet Dis. 2017;9(4):89–95.
  • Strassnig M, Signorile J, Gonzalez C, Harvey P. Physical performance and disability in schizophrenia. Schizophr Res: Cognition. 2014;1(2):112–21.
  • Breitling LP, Perna L, Müller H, Raum E, Kliegel M, Brenner H. Vitamin D and cognitive functioning in the elderly population in Germany. Exp Gerontol. 2012;47(1):122–7.
  • Darwish H, Zeinoun P, Ghusn H, Khoury B, Tamim H, Khoury SJ. Serum 25-hydroxyvitamin D predicts cognitive performance in adults. Neuropsychiatr Dis Treat. 2015;11:2217.
  • Wilson VK, Houston DK, Kilpatrick L, Lovato J, Yaffe K, Cauley JA, et al. Relationship between 25-hydroxyvitamin D and cognitive function in older adults: the health, aging and body composition study. J Am Geriatr Soc. 2014;62(4):636–41.
  • McCue RE, Charles RA, Orendain GC, Joseph MD, Abanishe JO. Vitamin D deficiency among psychiatric inpatients. The Primary Care Companion to CNS Disorders. 2012;14(2): PCC.11m01230.
  • Millan MJ, Agid Y, Brüne M, Bullmore ET, Carter CS, Clayton NS, et al. Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat Rev Drug Discovery. 2012;11(2):141–68.
  • Lai JK, Lucas RM, Armstrong M, Banks E. Prospective observational study of physical functioning, physical activity, and time outdoors and the risk of hip fracture: a population-based cohort study of 158,057 older adults in the 45 and up study. J Bone Miner Res. 2013;28(10):2222–31.
  • Lambert G, Reid C, Kaye D, Jennings G, Esler M. Increased suicide rate in the middle-aged and its association with hours of sunlight. Am J Psychiatry. 2003;160(4):793–5.
  • Kent ST, McClure LA, Crosson WL, Arnett DK, Wadley VG, Sathiakumar N. Effect of sunlight exposure on cognitive function among depressed and non-depressed participants: a REGARDS cross-sectional study. Environ Health. 2009;8(1):34.
  • Golden RN, Gaynes BN, Ekstrom RD, Hamer RM, Jacobsen FM, Suppes T, et al. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry. 2005;162(4):656–62.
  • Kesler SR, Adams HF, Blasey CM, Bigler ED. Premorbid intellectual functioning, education, and brain size in traumatic brain injury: an investigation of the cognitive reserve hypothesis. Appl Neuropsychol. 2003;10(3):153–62.
  • Le Carret N, Lafont S, Letenneur L, Dartigues J-F, Mayo W, Fabrigoule C. The effect of education on cognitive performances and its implication for the constitution of the cognitive reserve. Dev Neuropsychol. 2003;23(3):317–37.
  • Srinivasan L, Thara R, Tirupati S. Cognitive dysfunction and associated factors in patients with chronic schizophrenia. Indian J Psychiatry. 2005;47(3):139.
  • Lee S, Kawachi I, Berkman LF, Grodstein F. Education, other socioeconomic indicators, and cognitive function. Am J Epidemiol. 2003;157(8):712–20.
  • Wu F, Guo Y, Zheng Y, Ma W, Kowal P, Chatterji S, et al. Social-economic status and cognitive performance among Chinese aged 50 years and older. PloS one. 2016;11(11):e0166986.
  • Parisi JM, Rebok GW, Xue QL, Fried LP, Seeman TE, Tanner EK, et al. The role of education and intellectual activity on cognition. J Aging Res. 2012;2012:416132.
  • Basta NE, Matthews FE, Chatfield MD, Brayne C. MRC-CFAS. Community-level socio-economic status and cognitive and functional impairment in the older population. Eur J Public Health. 2008;18(1):48–54.
  • Wight RG, Aneshensel CS, Miller-Martinez D, Botticello AL, Cummings JR, Karlamangla AS, et al. Urban neighborhood context, educational attainment, and cognitive function among older adults. Am J Epidemiol. 2006;163(12):1071–8.
  • Firth J, Stubbs B, Vancampfort D, Schuch FB, Rosenbaum S, Ward PB, et al. The validity and value of self-reported physical activity and accelerometry in people with schizophrenia: a population-scale study of the UK Biobank. Schizophr Bull. 2017;44(6):1293–300.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.